Product Details

Therapeutic Categories

• Anti-inflammatory agent
• Enzyme

Use

Serratiopeptidase is promoted as an anti-inflammatory and mucolytic agent.

• As an anti-inflammatory agent for swelling due to surgery or trauma and for the treatment of chronic sinusitis and breast engorgement.
• as a mucolytic agent in patients with bronchitis, asthma, and tuberculosis, and for the clearing of bronchial secretions after surgery.

Dosing

The usual adult dosage of serrapeptase is 10 mg 3 times daily (range, 15 to 60 mg/day) 2 hours after meals. Serrapeptase has been taken for 1 to 2 weeks as an anti-inflammatory agent and up to 4 weeks as a mucolytic agent.

Adverse Reactions

• Rare, serious adverse effects reported with serrapeptase include eosinophilic pneumonitis, bullous pemphigoid, hemorrhage in a patient with Behcet disease, and possibly Stevens-Johnson syndrome.
• Hypersensitivity reactions and gastric pain have been reported.

Interactions:

Serratiopeptidase may increase the risk of bleeding with anticoagulants or antiplatelet drugs.

Source: Drug.com